Biomarker-stratified efficacy and safety of biologics in systemic lupus erythematosus: a systematic review and meta-analysis

Objective Biologics for systemic lupus erythematosus (SLE) demonstrate variable treatment responses across trials. We evaluated baseline biomarkers as predictors of response to guide personalised therapy selection.Methods We searched PubMed, OVID, Scopus, Cochrane and PsycInfo (January 2000–October...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Ahmed Y Azzam, Safi G Alqatari, Mohanad A Alkuwaiti, Faisal A Al-Harbi, Marj M Alabdullah, Adel A Zeidan, Noor H AlYousef, Mohammed A Alsaad, Rena Y Abualjamal, Feras Ahmed Alkuwaiti, Abdullah A Al-Abdulwahab, Hajer Musaab AlZuhair, Danya Y AlNujaidi, Nora A Alasaker, Manal A Hasan
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	BMJ Publishing Group 2026-03-01
Serie:	Lupus Science and Medicine
Accesso online:	https://lupus.bmj.com/content/13/1/e001920.full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!